[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Leigh Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 60 pages | ID: L13D65E8F7F5EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Leigh Syndrome, Is a subacute progressive genetic degeneration disease in infants and young children.

This report contains market size and forecasts of Leigh Syndrome Treatment in Global, including the following market information:

Global Leigh Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Leigh Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leigh Syndrome Treatment include GSK, Brother Enterprises, Huazhong Pharma, Zhejiang Tianxin, Stryker, Zimmer Biomet Holdings, Wright Medical Technology and Integra LifeSciences Holdings Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leigh Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leigh Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Leigh Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)
  • Medications
  • Surgery
  • Others
Global Leigh Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Leigh Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Clinic
  • Others
Global Leigh Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Leigh Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Leigh Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Leigh Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • GSK
  • Brother Enterprises
  • Huazhong Pharma
  • Zhejiang Tianxin
  • Stryker
  • Zimmer Biomet Holdings
  • Wright Medical Technology
  • Integra LifeSciences Holdings Corporation
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Leigh Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Leigh Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEIGH SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Leigh Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Leigh Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Leigh Syndrome Treatment Players in Global Market
3.2 Top Global Leigh Syndrome Treatment Companies Ranked by Revenue
3.3 Global Leigh Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Leigh Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Leigh Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leigh Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Leigh Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Leigh Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Leigh Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medications
  4.1.3 Surgery
  4.1.4 Others
4.2 By Type - Global Leigh Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Leigh Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Leigh Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Leigh Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Leigh Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Leigh Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Leigh Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Leigh Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Leigh Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Leigh Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Leigh Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Leigh Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Leigh Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Leigh Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Leigh Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Leigh Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Leigh Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Leigh Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Leigh Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Leigh Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Leigh Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Leigh Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Leigh Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Leigh Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Leigh Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Leigh Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Leigh Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Leigh Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Leigh Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Leigh Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Leigh Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Leigh Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Leigh Syndrome Treatment Major Product Offerings
  7.1.4 GSK Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Brother Enterprises
  7.2.1 Brother Enterprises Corporate Summary
  7.2.2 Brother Enterprises Business Overview
  7.2.3 Brother Enterprises Leigh Syndrome Treatment Major Product Offerings
  7.2.4 Brother Enterprises Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Brother Enterprises Key News
7.3 Huazhong Pharma
  7.3.1 Huazhong Pharma Corporate Summary
  7.3.2 Huazhong Pharma Business Overview
  7.3.3 Huazhong Pharma Leigh Syndrome Treatment Major Product Offerings
  7.3.4 Huazhong Pharma Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Huazhong Pharma Key News
7.4 Zhejiang Tianxin
  7.4.1 Zhejiang Tianxin Corporate Summary
  7.4.2 Zhejiang Tianxin Business Overview
  7.4.3 Zhejiang Tianxin Leigh Syndrome Treatment Major Product Offerings
  7.4.4 Zhejiang Tianxin Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Zhejiang Tianxin Key News
7.5 Stryker
  7.5.1 Stryker Corporate Summary
  7.5.2 Stryker Business Overview
  7.5.3 Stryker Leigh Syndrome Treatment Major Product Offerings
  7.5.4 Stryker Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 Stryker Key News
7.6 Zimmer Biomet Holdings
  7.6.1 Zimmer Biomet Holdings Corporate Summary
  7.6.2 Zimmer Biomet Holdings Business Overview
  7.6.3 Zimmer Biomet Holdings Leigh Syndrome Treatment Major Product Offerings
  7.6.4 Zimmer Biomet Holdings Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Zimmer Biomet Holdings Key News
7.7 Wright Medical Technology
  7.7.1 Wright Medical Technology Corporate Summary
  7.7.2 Wright Medical Technology Business Overview
  7.7.3 Wright Medical Technology Leigh Syndrome Treatment Major Product Offerings
  7.7.4 Wright Medical Technology Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.7.5 Wright Medical Technology Key News
7.8 Integra LifeSciences Holdings Corporation
  7.8.1 Integra LifeSciences Holdings Corporation Corporate Summary
  7.8.2 Integra LifeSciences Holdings Corporation Business Overview
  7.8.3 Integra LifeSciences Holdings Corporation Leigh Syndrome Treatment Major Product Offerings
  7.8.4 Integra LifeSciences Holdings Corporation Leigh Syndrome Treatment Revenue in Global Market (2017-2022)
  7.8.5 Integra LifeSciences Holdings Corporation Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Leigh Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Leigh Syndrome Treatment Market Drivers in Global Market
Table 3. Leigh Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Leigh Syndrome Treatment in Global Market
Table 5. Top Leigh Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Leigh Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Leigh Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Leigh Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Leigh Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leigh Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Leigh Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Leigh Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Leigh Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Leigh Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Leigh Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Leigh Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Leigh Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Leigh Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Leigh Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Leigh Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Leigh Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Leigh Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Leigh Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Leigh Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Leigh Syndrome Treatment Product Offerings
Table 32. GSK Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Brother Enterprises Corporate Summary
Table 34. Brother Enterprises Leigh Syndrome Treatment Product Offerings
Table 35. Brother Enterprises Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Huazhong Pharma Corporate Summary
Table 37. Huazhong Pharma Leigh Syndrome Treatment Product Offerings
Table 38. Huazhong Pharma Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Zhejiang Tianxin Corporate Summary
Table 40. Zhejiang Tianxin Leigh Syndrome Treatment Product Offerings
Table 41. Zhejiang Tianxin Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Stryker Corporate Summary
Table 43. Stryker Leigh Syndrome Treatment Product Offerings
Table 44. Stryker Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Zimmer Biomet Holdings Corporate Summary
Table 46. Zimmer Biomet Holdings Leigh Syndrome Treatment Product Offerings
Table 47. Zimmer Biomet Holdings Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Wright Medical Technology Corporate Summary
Table 49. Wright Medical Technology Leigh Syndrome Treatment Product Offerings
Table 50. Wright Medical Technology Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Integra LifeSciences Holdings Corporation Corporate Summary
Table 52. Integra LifeSciences Holdings Corporation Leigh Syndrome Treatment Product Offerings
Table 53. Integra LifeSciences Holdings Corporation Leigh Syndrome Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Leigh Syndrome Treatment Segment by Type in 2021
Figure 2. Leigh Syndrome Treatment Segment by Application in 2021
Figure 3. Global Leigh Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Leigh Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Leigh Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leigh Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Leigh Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Leigh Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Brother Enterprises Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Huazhong Pharma Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zhejiang Tianxin Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Stryker Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Zimmer Biomet Holdings Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Wright Medical Technology Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Integra LifeSciences Holdings Corporation Leigh Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications